GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $33,164 | -97.0% | 17,007 | -95.8% | 0.00% | – |
Q1 2023 | $1,113,693 | +370.2% | 400,609 | +483.5% | 0.00% | – |
Q4 2022 | $236,880 | +68.0% | 68,661 | +25.4% | 0.00% | – |
Q3 2022 | $141,000 | -28.1% | 54,771 | -32.5% | 0.00% | – |
Q2 2022 | $196,000 | -88.4% | 81,115 | -80.2% | 0.00% | – |
Q1 2022 | $1,690,000 | -39.1% | 410,159 | +90.2% | 0.00% | – |
Q4 2021 | $2,774,000 | -16.1% | 215,612 | -29.5% | 0.00% | -100.0% |
Q3 2021 | $3,305,000 | +736.7% | 305,945 | +630.9% | 0.00% | – |
Q1 2021 | $395,000 | +1134.4% | 41,861 | +251.1% | 0.00% | – |
Q3 2020 | $32,000 | – | 11,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |